Investor insights
Sectors invested in
Medical1
TCR-based Immunotherapies1
TCR Discovery1
Peptidomics & mass spectrometry1
Bioinformatics1
Adoptive Cell Therapy1
Cancer1
Discovery of HLA-restricted tumor-associated peptides as cancer targets1
Biotechnology1
Immunomonitoring1
TCR Bispecifics1
Bispecific Development1
Standardized PBMC collection1
Therapeutics1
Biomarkers1
Immunology1
Funding rounds participated in
$110M sweet spot round size
Most of their 1 investments are in rounds between $110M and $110M
Investor type
Hedge Fund
Basic info
Industry
investment management
Sectors
biotechnology
medical devices
hedge fund
life sciences
pharmaceuticals
healthcare
Date founded
2020
Investments made
I
Immatics Biotechnologies raised $110M on October 10, 2022
Investors: Wellington Management, RTW Investments, LP, Sofinnova Ventures, Russia technology fund, Perceptive Advisors, Samsara BioCapital and Dellora Investments